Tortugas debuts with $106M and brain drugs from Hansoh, Eisai
Source: BioPharma Dive - Latest News
Led by former Sage Therapeutics executives Jeff Jonas and Al Robichaud, the company is starting out with a portfolio of neurological medicines in clinical testing.